(3R,4R,5R)-3-(BETA-D-GLUCOPYRANOSYL)-OXY-4-HYDROXY-5-(HYDROXYMETHYL)-PIPERIDINE-[3-O-(BETA-D-GLUCOPYRANOSYL)-ISOFAGOMINE]
Compound with spectra: 1 NMR
![(3R,4R,5R)-3-(BETA-D-GLUCOPYRANOSYL)-OXY-4-HYDROXY-5-(HYDROXYMETHYL)-PIPERIDINE-[3-O-(BETA-D-GLUCOPYRANOSYL)-ISOFAGOMINE]](/api/compound/HxEGUaPgEPb.png?ph=true&h=300&w=458 "(3R,4R,5R)-3-(BETA-D-GLUCOPYRANOSYL)-OXY-4-HYDROXY-5-(HYDROXYMETHYL)-PIPERIDINE-[3-O-(BETA-D-GLUCOPYRANOSYL)-ISOFAGOMINE]")
| SpectraBase Compound ID | HxEGUaPgEPb |
|---|---|
| InChI | InChI=1S/C12H23NO8/c14-3-5-1-13-2-6(8(5)16)20-12-11(19)10(18)9(17)7(4-15)21-12/h5-19H,1-4H2/t5-,6-,7+,8-,9+,10-,11+,12+/m1/s1 |
| InChIKey | BEXVSXHKIARRKH-VMZJDCPZSA-N |
| Mol Weight | 309.32 g/mol |
| Molecular Formula | C12H23NO8 |
| Exact Mass | 309.142367 g/mol |
| Enantiomer InChIKey | BEXVSXHKIARRKH-GIBQNNFTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
(4R,5S,6R)-4-(BETA-D-GLUCOPYRANOSYL)-OXY-5-HYDROXY-6-HYDROXYMETHYL-3,4,5,6-TETRAHYDRO-1,2(2H)-OXAZINE
BETA-D-GLC-P-(1->4)-XYL-PA;PA-1
6-AMINO-1,5-ANHYDRO-2,6-DIDEOXY-3-O-(ALPHA-D-GLUCOPYRANOSYL)-D-ARABINO-HEXITOL-HYDROCHLORIDE
1,5-ANHYDRO-2-DEOXY-3-O-(ALPHA-D-GLUCOPYRANOSYL)-6-O-METHYL-D-ARABINO-HEXITOL
KIJOLANITOL-1-O-BETA-D-GLUCOPYRANOSIDE
METHYL 4-O-(ALPHA-D-GLUCOPYRANOSYL)-BETA-D-XYLOPYRANOSIDE
METHYL 4-O-(BETA-D-GLUCOPYRANOSYL)-BETA-D-XYLOPYRANOSIDE
(R)-(-)-6,6'-DIDEOXY-6,6'-BIS-[1-(HYDROXYMETHYL)-PROPYLAMINO]-ALPHA,ALPHA-TREHALOSE
3-O.beta.-D-Galactopyranosyl-L-rhamnose
1,4,5-TRIDEOXY-3-O-(ALPHA-D-GLUCOPYRANOSYL)-1,5-IMINO-D-XYLO-HEXITOL-HYDROCHLORIDE
| Title | Journal or Book | Year |
|---|---|---|
| The Synthesis of 3-O-(β-D-Glucopyranosyl)- and 3-O-(β-Laminaribiosyl)-isofagomines, Potent Inhibitors of a 1,3-β-D-Glucan endo-Hydrolase | Australian Journal of Chemistry | 2004 |